Forte Biosciences, Inc. (FBRX) earnings
FBRX earnings moved a median of +0.04% by the close. Quarterly and annual FBRX reports and results, each read against the price at its own news timestamp. Back to the FBRX overview →
16 measured FBRX earnings events.
Where these FBRX earnings landedvs 16 measured FBRX earnings reactions
| Middle 50% of FBRX earnings reactions | -4.85% to +3.56% |
|---|---|
| Median reaction (to close) | +0.04% |
| Measured reactions | 16 |
Point-in-time · zero look-ahead
Half of the 16 FBRX earnings events with a measured close landed between -4.85% and +3.56%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Forte Biosciences, Inc. Announces First Quarter 2026 Results and Provides Update | Press release | +1.60% | +11.16% | |
| Form 10-Q Forte Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | +1.44% | +4.14% | |
| Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update | Press release | +1.44% | +4.14% | |
| Form 10-Q Forte Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +5.28% | |
| Form 10-Q Forte Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.12% | -2.97% | |
| Form 10-K Forte Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | -5.09% | -14.16% | |
| Form 10-Q Forte Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | -3.54% | +3.36% | |
| Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update | Press release | -3.54% | +3.36% | |
| Form 10-Q Forte Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.91% | -20.51% | |
| Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update | Press release | +1.91% | -20.51% | |
| Form 10-Q Forte Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -1.45% | |
| Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update | Press release | +0.00% | -1.45% | |
| Form 10-K/A Forte Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | — | +1.71% | |
| Form 10-K Forte Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +1.54% | |
| Form 10-Q Forte Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -4.85% | |
| Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update | Press release | +0.00% | -4.85% |
Keep exploring
More FBRX: analyst actions → · SEC filings → · FBRX overview →